Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with long acting beta‐2 agonists (LABAs) and anticholinergic bronchodilator medications, both of which are recomm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Main Authors: Appleton, Sarah, Jones, Terry, Poole, Phillippa, Lasserson, Toby J, Adams, Robert, Smith, Brian J, Muhammed, Julia
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd 2006
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7200053/
https://ncbi.nlm.nih.gov/pubmed/16856113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006101
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares